SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-23-008914
Filing Date
2023-03-24
Accepted
2023-03-24 17:00:20
Documents
78
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 2568678
2 ex4-21.htm EX-4.21 54394
3 ex21-1.htm EX-21.1 2642
4 ex31-1.htm EX-31.1 17782
5 ex31-2.htm EX-31.2 18314
6 ex32-1.htm EX-32.1 8183
7 ex32-2.htm EX-32.2 7515
8 form10-k_001.jpg GRAPHIC 97337
  Complete submission text file 0001493152-23-008914.txt   9035866

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE mrzm-20221231.xsd EX-101.SCH 57815
10 XBRL CALCULATION FILE mrzm-20221231_cal.xml EX-101.CAL 65890
11 XBRL DEFINITION FILE mrzm-20221231_def.xml EX-101.DEF 256546
12 XBRL LABEL FILE mrzm-20221231_lab.xml EX-101.LAB 501796
13 XBRL PRESENTATION FILE mrzm-20221231_pre.xml EX-101.PRE 388889
72 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 1073119
Mailing Address 555 HERITAGE DRIVE SUITE 205 JUPITER FL 33458
Business Address 555 HERITAGE DRIVE SUITE 205 JUPITER FL 33458 561-935-9955
MARIZYME INC (Filer) CIK: 0001413754 (see all company filings)

IRS No.: 825464863 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-53223 | Film No.: 23760624
SIC: 2834 Pharmaceutical Preparations